For breast cancer, reported mammaglobin-A positivity rates range from 59 to 100% in lobular breast carcinomas [21,22] and from 25 to 94% in invasive breast carcinomas of no special type [23,24]. This evidence concerns the gene SCGB2A2 and breast carcinoma.